术前内镜逆行胰胆管造影与胰腺癌死亡率增加无关
该研究利用监测、流行病学和最终结果(SEER)数据库与医疗保险理赔数据,纳入2000年至2011年间年龄大于65岁、肿瘤局限于胰头的胰腺癌患者。在接受手术切除的患者中,调整混杂因素后发现,术前接受内镜逆行胰胆管造影(ERCP)者与直接手术者相比死亡风险未增加(风险比1.02,95%CI 0.96-1.08)。
要点
- 在接受胰腺癌手术切除的患者中,术前ERCP未增加死亡风险(HR 1.02,95%CI 0.96-1.08)。
- 研究纳入16670例胰头癌患者,其中2890例(17.3%)接受手术切除,1864例(64.5%)术前接受ERCP。
- 作者认为需要研究以识别可能从该操作中获益的患者亚群。
核心结论
- 在接受手术的胰腺癌患者中,术前接受ERCP者与直接手术者相比死亡风险未增加(HR 1.02,95%CI 0.96-1.08)。
- 作者认为需要研究以识别可能从该操作中获益的患者亚群。
研究设计与样本
- 研究利用监测、流行病学和最终结果(SEER)数据库与医疗保险理赔关联数据,纳入2000年至2011年间年龄大于65岁、肿瘤局限于胰头的胰腺癌患者。
- 采用逆倾向加权Cox比例风险模型评估ERCP对接受胰腺癌手术患者生存的影响。
主要发现
- 在16670例胰头癌患者中,2890例(17.3%)接受手术切除,其中1864例(64.5%)术前接受ERCP。
- 调整混杂因素后,术前接受ERCP者与仅接受手术切除者相比死亡风险未增加(HR 1.02,95%CI 0.96-1.08)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需要研究以识别可能从该操作中获益的患者亚群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Endoscopic retrograde cholangiopancreatography (ERCP) before surgery for pancreatic cancer has been associated with infectious complications after surgery. Little is known about the effects of preoperative ERCP on the survival of patients with pancreatic cancer. We investigated whether ERCP before surgery affects overall survival, after controlling for confounding factors. METHODS: We used Surveillance, Epidemiology, and End Results (SEER) and linked Medicare claims data to identify patients older than 65 years with cancer localized to the head of the pancreas, from 2000 through 2011. We used inverse propensity-weighted Cox proportional hazard models to assess the effects of ERCP on the survival of patients who underwent surgery for pancreatic cancer. RESULTS: Among 16,670 patients with cancer of the head of the pancreas, 2890 (17.3%) underwent surgical resection; 1864 (64.5%) of these patients received preoperative ERCP. After we adjusted for confounders, we found that patients who received preoperative ERCP did not have an increased risk of death compared with patients who underwent resection alone (hazard ratio, 1.02; 95% CI, 0.96-1.08). CONCLUSIONS: Patients with pancreatic cancer who underwent ERCP before surgery did not have an increased risk of death compared with patients who proceeded directly to surgery. Studies are needed to identify subsets of patients who may benefit from this procedure.
引用
- Rustgi SD, Amin S, Yang A, et al. Preoperative Endoscopic Retrograde Cholangiopancreatography Is Not Associated With Increased Pancreatic Cancer Mortality. Clin Gastroenterol Hepatol. 2018. PMID: 30529734. doi:10.1016/j.cgh.2018.11.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。